Re: Inventiva Pharma
Geplaatst: 27 sep 2022 12:03
Beursforum voor de belegger uit Nederland en België, de beurs, beleggen, aandelen kopen, goud, beursnieuws beurs vandaag, AEX en BEL 20, brokers vergelijken.
https://beursig.com/forum/
NewB76 schreef: ↑22 sep 2022 14:48
Upcoming investor conference participation
Innovation Days – HealthTechOctober 12-14, Paris
Portzamparc BNP Paribas Biotech & Santé – October 4, Virtual
H.C. Wainwright 6th Annual NASH Investor Conference – October 17, Virtual
Jefferies 2022 London Healthcare Conference – November 15-17, London
Upcoming scientific conference participation
91èmes Journées Scientifiques de l’AFEF – October 5-8, Dijon
AASLD - The Liver Meeting – November 4-8, Washington, DC
6th Obesity and NASH Drug Development Summit – November 29 through December 1, Boston
MOSAIC Conference – December 5-6, Washington, DC
https://inventivapharma.com/wp-content/ ... -FINAL.pdf
zit dik te twijfelen. Voor 0.02cent mijn buy laten mislukken dinsdag/woe nu wel pijnlijk.
Cedirogant lijkt belangrijk alsook cash-positie welke precies verlengd geraakt tot in Q4NewB76 schreef: ↑22 sep 2022 14:40Sept 22 (Reuters) - INVENTIVA SA :
* STUDY COMPLETION OF PHASE IIB TRIAL WITH CEDIROGANT IN PATIENTS WITH PSORIASIS CONDUCTED BY ABBVIE - PLANNED FOR FIRST HALF OF 2023
* ESTIMATES THAT ITS EXISTING CASH, CASH EQUIVALENTS AND SHORT-TERM DEPOSITS SHOULD ALLOW COMPANY TO FUND ITS OPERATIONS THROUGH Q4 2023
* END-JUNE NET OPERATING LOSS EUR 33.5 MLN VS LOSS EUR 23.6 MLN YR GO